Stock listing

Moberg Pharma Ab

Selected listing: A3EGXK · LS · EUR · DE

Moberg Pharma Ab (Lang & Schwarz: A3EGXK), Health Technology. Latest release Oct 5, 2026: New analyses on terbinafine susceptibility and MOB-015 published…

A3EGXK:LSEURDEUpdated September 26, 2026

Ticker: Lang & Schwarz: A3EGXK
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Moberg Pharma Ab

New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi

October 5, 2026

Moberg Pharma's Terclara[® ](MOB-015) launched in Israel

September 23, 2026

M O B A Network : Proposal for an up to SEK 11.3 million directed share issue in M.O.B.A. to secure obligations under its outstanding bonds

September 14, 2026

Moberg Pharma strengthens organization ahead of European launch

August 11, 2026

New number of shares and votes in Moberg Pharma AB (publ)

June 30, 2026

All Moberg Pharma Ab news →

Events

Replays

Moberg Pharma AB (publ) (MOB) Q4 2024 Earnings Call
Tue, Feb 11, 2025 · 09:00 AM ET
Watch
Moberg Pharma AB (publ) (MOB) Q3 2024 Earnings Call
Tue, Nov 12, 2024 · 09:30 AM ET
Watch
Moberg Pharma AB (publ) (MOB) Q2 2024 Earnings Call
Tue, Aug 13, 2024 · 05:30 AM ET
Watch

Research Moberg Pharma Ab

Moberg Pharma Ab company profile

View the public company page for Moberg Pharma Ab on 6ix.

Moberg Pharma Ab news

Read company news and market updates connected to Moberg Pharma Ab.

Moberg Pharma Ab investor events

Find investor webinars, events, and replay context for Moberg Pharma Ab.